Agricultural Compounds and Veterinary Medicines Act 1997 No 87 (as at 18 October 2007), Public Act

20 Evaluation of risks and benefits
  • The Director-General must, when evaluating the risks and benefits under section 21, have regard to—

    • (a) All relevant scientific and technical information held by the Director-General other than information protected in accordance with section 73, section 109, or section 121; and

    • (b) New Zealand's international obligations, assurances, and reputation; and

    • (c) Any submissions received under section 17.